Statistics

Total Visits

Views
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase 16
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase 11

Total Visits per Month

July 2021 August 2021 September 2021 October 2021 November 2021 December 2021 January 2022
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase 0 0 0 6 0 10 0
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase(legacy) 0 2 1 0 0 0 0

File Downloads

Views

Top Country Views

Views
United States 9
Netherlands 8
Australia 1
France 1
Vietnam 1

Top City Views

Views
Rotterdam 8
Ashburn 4
Augusta 1
Cambridge 1
Fairfield 1
Hanoi 1
Kaleen 1
Redwood City 1
San Diego 1